Standard BioTools Second Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Standard BioTools Inc. (LAB)
Company Research
Source: Yahoo! Finance
Net loss: US$45.7m (loss widened by 168% from 2Q 2023). US$0.12 loss per share. All figures shown in the chart above are for the trailing 12 month (TTM) period Standard BioTools Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 23%. Earnings per share (EPS) also missed analyst estimates by 33%. Looking ahead, revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 6.7% growth forecast for the Life Sciences industry in the US. Performance of the American Life Sciences industry. The company's shares are up 18% from a week ago. Risk Analysis Don't forget that there may still be risks. For instance, we've identified 3 warning signs for Standard BioTools (1 is a bit concerning) you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide
Show less
Read more
Impact Snapshot
Event Time:
LAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LAB alerts
High impacting Standard BioTools Inc. news events
Weekly update
A roundup of the hottest topics
LAB
News
- Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K PlatformGlobeNewswire
- Shareholders in Standard BioTools (NASDAQ:LAB) are in the red if they invested three years ago [Yahoo! Finance]Yahoo! Finance
- Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)GlobeNewswire
- Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceGlobeNewswire
- Standard BioTools to Participate in Upcoming Investor ConferencesGlobeNewswire
LAB
Earnings
- 7/31/24 - Miss
LAB
Sec Filings
- 9/9/24 - Form 144
- 9/5/24 - Form 4
- 9/5/24 - Form 4
- LAB's page on the SEC website